Kaplan-Meier survival analyses indicated a trend towards shorter overall survival (OS) in patients harboring ANKRD11 mutations compared to those without, although this difference did not reach statistical significance (P=0.24) ( Figure 2C ).
← all excerpts
<i>ANKRD11</i> as a potential biomarker for brain metastasis from lung adenocarcinoma via cerebrospinal fluid liquid biopsy.
1
0.2400
0.2400